These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34854794)

  • 1. Interagency approaches to animal models for acute radiation exposure.
    Hunter KS; Carnell LS; DiCarlo AL; Hoffman CM; Loelius SG; Homer M
    Int J Radiat Biol; 2021; 97(sup1):S2-S5. PubMed ID: 34854794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal Care in Radiation Medical Countermeasures Studies.
    Rios CI; Hollingsworth BA; DiCarlo AL; Esker JE; Satyamitra MM; Silverman TA; Winters TA; Taliaferro LP
    Radiat Res; 2022 Nov; 198(5):514-535. PubMed ID: 36001810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Product Development within the National Institutes of Health Radiation and Nuclear Countermeasures Program.
    Cassatt DR; DiCarlo AL; Molinar-Inglis O
    Radiat Res; 2024 May; 201(5):471-478. PubMed ID: 38407357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIH Policies and Regulatory Pathways to U.S. FDA licensure: Strategies to Inform Advancement of Radiation Medical Countermeasures and Biodosimetry Devices.
    Satyamitra MM; Perez-Horta Z; DiCarlo AL; Cassatt DR; Rios CI; Price PW; Taliaferro LP
    Radiat Res; 2022 May; 197(5):533-553. PubMed ID: 35113982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)-August 6/7, 2019.
    Yeung DT; Bough KJ; Harper JR; Platoff GE
    J Med Toxicol; 2020 Jan; 16(1):87-105. PubMed ID: 31853736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical countermeasures for platelet regeneration after radiation exposure. Report of a workshop and guided discussion sponsored by the National Institute of Allergy and Infectious Diseases, Bethesda, MD, March 22–23, 2010.
    DiCarlo AL; Poncz M; Cassatt DR; Shah JR; Czarniecki CW; Maidment BW
    Radiat Res; 2011 Jul; 176(1):e0001-15. PubMed ID: 21545291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Trans-Agency Workshop on the Pathophysiology of Radiation-Induced Lung Injury.
    Cassatt DR; Gorovets A; Karimi-Shah B; Roberts R; Price PW; Satyamitra MM; Todd N; Wang SJ; Marzella L
    Radiat Res; 2022 Apr; 197(4):415-433. PubMed ID: 34342637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Trans-Agency Workshop on the Pathophysiology of Radiation-Induced Lung Injury.
    Satyamitra MM; Cassatt DR; Marzella L
    Radiat Res; 2022 Apr; 197(4):408-414. PubMed ID: 34714907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in medical countermeasure development against acute radiation exposure based on the US FDA animal rule.
    MacVittie TJ; Farese AM
    J Radiol Prot; 2021 Nov; 41(4):. PubMed ID: 34433144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal Acute Radiation Syndrome: Mechanisms, Models, Markers, and Medical Countermeasures.
    Winters TA; Marzella L; Molinar-Inglis O; Price PW; Han NC; Cohen JE; Wang SJ; Fotenos AF; Sullivan JM; Esker JI; Lapinskas PJ; DiCarlo AL
    Radiat Res; 2024 Jun; 201(6):628-646. PubMed ID: 38616048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Biomarkers for Radiation Biodosimetry and Medical Countermeasures Research: Current Status, Utility, and Regulatory Pathways.
    Satyamitra MM; DiCarlo AL; Hollingsworth BA; Winters TA; Taliaferro LP
    Radiat Res; 2022 May; 197(5):514-532. PubMed ID: 34879151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building the strategic national stockpile through the NIAID Radiation Nuclear Countermeasures Program.
    Rios CI; Cassatt DR; Dicarlo AL; Macchiarini F; Ramakrishnan N; Norman MK; Maidment BW
    Drug Dev Res; 2014 Feb; 75(1):23-8. PubMed ID: 24648046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Pathophysiology and Challenges of Development of Medical Countermeasures for Radiation-Induced Vascular/Endothelial Cell Injuries: Report of a NIAID Workshop, August 20, 2015.
    Satyamitra MM; DiCarlo AL; Taliaferro L
    Radiat Res; 2016 Aug; 186(2):99-111. PubMed ID: 27387859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models for acute radiation syndrome drug discovery.
    Singh VK; Newman VL; Berg AN; MacVittie TJ
    Expert Opin Drug Discov; 2015 May; 10(5):497-517. PubMed ID: 25819367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous Radiation Injuries: Models, Assessment and Treatments.
    DiCarlo AL; Bandremer AC; Hollingsworth BA; Kasim S; Laniyonu A; Todd NF; Wang SJ; Wertheimer ER; Rios CI
    Radiat Res; 2020 Sep; 194(3):315-344. PubMed ID: 32857831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meeting Report: A Poly-Pharmacy Approach to Mitigate Acute Radiation Syndrome.
    Taliaferro LP; Cassatt DR; Horta ZP; Satyamitra MM
    Radiat Res; 2021 Oct; 196(4):436-446. PubMed ID: 34237144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIAID/NIH radiation/nuclear medical countermeasures product research and development program.
    Hafer N; Cassatt D; Dicarlo A; Ramakrishnan N; Kaminski J; Norman MK; Maidment B; Hatchett R
    Health Phys; 2010 Jun; 98(6):903-5. PubMed ID: 20445403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and licensure of medical countermeasures to treat lung damage resulting from a radiological or nuclear incident.
    DiCarlo AL; Jackson IL; Shah JR; Czarniecki CW; Maidment BW; Williams JP
    Radiat Res; 2012 May; 177(5):717-21. PubMed ID: 22468704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-agency perspective: Translating advances in biomarker discovery and medical countermeasures development between terrestrial and space radiation environments.
    DiCarlo AL; Carnell LS; Rios CI; Prasanna PG
    Life Sci Space Res (Amst); 2022 Nov; 35():9-19. PubMed ID: 36336375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of gamma-tocotrienol as a radiation medical countermeasure for the acute radiation syndrome: current status and future perspectives.
    Singh VK; Seed TM
    Expert Opin Investig Drugs; 2023 Jan; 32(1):25-35. PubMed ID: 36655861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.